跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Saphlocid - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Saphlocid
Approved
STANDARD
Saphlocid
Sapphire Lifesciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
81d20e8d13b88039
Company
Sapphire Lifesciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
81d20e8d13b88039
Drug Approval Philippines Name
Saphlocid
Product Name
Saphlocid
Registration Number
DRP-5609
Brand Name
Saphlocid
Generic Name
Diclofenac Sodium
Dosage Form
Enteric Coated Tablet
Dosage Strength
50mg
Manufacturer
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Distributor
Nelpa Lifesciences, Inc.
Issuance Date
28 August 2024
Expiry Date
15 October 2029
Pharmacologic Category
Non-Steroidal Anti-inflammatory Drug (NSAID)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
81d20e8d13b88039
Type
Standard
Back to Philippines FDA Approvals